Brain Cancer

Ultrasound Technique Delivers Paclitaxel Across Blood-Brain Barrier in Glioblastoma

By

Leah Lawrence

Publish Date May 23, 2023

An ultrasound technique allows for delivery of albumin-bound paclitaxel across the blood-brain barrier in patients with recurrent glioblastoma, a study suggests.

Food Deserts, Swamps Linked to Increased Risk of Death From Obesity-Related Cancers

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date May 12, 2023

US counties with food deserts or food swamps tend to have higher rates of death from obesity-related cancers, a study suggests.

ART and Pediatric Cancer: Risk May Vary by Method Used, Cancer Type

By

Carina Storrs, PhD

Publish Date May 10, 2023

Research has suggested that ART may increase the risk of pediatric cancers, but studies have shown conflicting results, and questions remain.

CAR T Cells Targeting GD2 Feasible, Safe for Pediatric Neuroblastoma

Publish Date April 17, 2023

GD2-targeted CAR T cells expanded in vivo, and were detectable in peripheral blood up to 30 months after infusion.

Oncologists Disagree on Treatment and Curability of Oligometastatic Cancer

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date April 14, 2023

Oncologists have differing opinions on whether oligometastatic cancer is curable and how it should be treated, a survey suggests.

Brain Cancer Clinical Trials

Transplant From Deceased Donor With Brain Tumor Appears to Be Safe

Risk for cancer transmission lower than thought, and long-term transplant outcomes favorable.

Aspirin and Metformin Combo Linked to Higher Risk of Cancer Death

Among older patients with diabetes, metformin was associated with a reduced risk of cancer, but the combination of aspirin and metformin was associated with an increased risk of cancer death.

Nurse-Parent Collaboration Key to Successful ¹³¹I-MIBG Therapy for Neuroblastoma

A qualitative descriptive study was conducted to learn about nurses’ experiences administering care to pediatric patients with neuroblastoma who are receiving radioactive therapy.

Interferon Alfa Improves Upon Standard Care in High Grade Glioma

Adding interferon alfa to treatment with temozolomide and radiotherapy prolongs survival in patients with newly diagnosed, high grade glioma, a phase 3 trial suggests.

Extent of Tumor Resection Linked to Overall Survival in Low-Grade Glioma

Survival outcomes improved with extent of tumor resection ≥75 percent for patients with grade 2 glioma.